Board Meetings for LINCOLN
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| LINCOLN | Lincoln Pharmaceuticals Limited | 30 May 2019 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2019, dividend and other business matters | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 28 Mar 2019 | Other business matters | To consider other business matters as appointment of CFO and Secretarial Auditor of the Company. | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 12 Feb 2019 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2018 and other business matters | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 14 Nov 2018 | Financial Results | To consider and approve the financial results for the period ended September 30, 2018 | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 14 Aug 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 30 May 2018 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2018 and other business matters | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 31 Jan 2018 | Results | inter-alia to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine-Months Ended on December 31, 2017. | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 12 Dec 2017 | Results | Inter-alia to consider and approve the Un-Audited Consolidated and Standalone Financial Results of the Company for the Quarter and Half Year Ended on September 30, 2017. | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 14 Sept 2017 | Results | inter alia to consider and approve the un-audited Consolidated and standalone Financial results of the Company for the quarter ended on June 30, 2017. | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 30 May 2017 | Results/Dividend | To consider the following businesses: 1. Approval and adoption of Audited Consolidated and Standalone Financial results of the Company for the Quarter and Year ended on March 31, 2017. 2. Recommendation of dividend on Equity Shares of the Company for the Financial Year ended on March 31, 2017, if any. 3. Any other matter with the approval of the chair. | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 09 Feb 2017 | Results | To consider and approve the Un-audited Consolidated and Standalone Financial Results of the Company for the Quarter ended on December 31, 2016. | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 10 Nov 2016 | Results/Others | to consider and approve the following: 1. Un-audited Consolidated and Standalone Financial Results of the Company for the Quarter and half year ended on September 30, 2016. 2. Delisting of Equity Shares of the Company from Ahmedabad Stock Exchange Limited pursuant to SEBI (Delisting of Equity Shares) Regulations, 2009. As amended from time to time. | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 27 Oct 2016 | Meeting Updates | To Issue and Allotment of Equity Shares against Conversion of Warrant Issue to Promoter/Promoter Group and Non-Promoter warrant holders. | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 11 Aug 2016 | Results | to consider and approve the Quarterly Unaudited Financial Results for the aforesaid quarter and also to consider any other business if any. | |
| LINCOLN | Lincoln Pharmaceuticals Limited | 30 May 2016 | Results/Dividend | To Consider and approve the Quarterly / Yearly Audited Financial Results for the aforsaid Quarter / Year end and to consider recommendation of Dividend, if any on the Equity Shares of the Company. |